Hospital of the University of Pennsylvania, Department of Radiology, 1 Silverstein, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Br J Radiol. 2010 Apr;83(988):344-50. doi: 10.1259/bjr/80279516. Epub 2009 Jun 8.
Contrast-enhanced digital breast tomosynthesis (CE-DBT) is a novel modality for imaging breast lesion morphology and vascularity. The purpose of this study is to assess the feasibility of dual-energy subtraction as a technique for CE-DBT (a temporal subtraction CE-DBT technique has been described previously). As CE-DBT evolves, exploration of alternative image acquisition techniques will contribute to its optimisation. Evaluation of dual-energy CE-DBT was conducted with Institutional Review Board (IRB) approval from our institution and in compliance with federal Health Insurance Portability and Accountability Act (HIPAA) guidelines. A 55-year old patient with a known malignancy in the right breast underwent imaging with MRI and CE-DBT. CE-DBT was performed in the medial lateral oblique view with a DBT system, which was modified under IRB approval to allow high-energy image acquisition with a 0.25 mm Cu filter. Image acquisition occurred via both temporal and dual-energy subtraction CE-DBT. Between the pre- and post-contrast DBT image sets, a single bolus of iodinated contrast agent (1.0 ml kg(-1)) was administered, followed by a 60 ml saline flush. The contrast agent and saline were administrated manually at a rate of approximately 2 ml s(-1). Images were reconstructed using filtered-back projection and transmitted to a clinical PACS workstation. Dual-energy CE-DBT was shown to be clinically feasible. In our index case, the dual-energy technique was able to provide morphology and kinetic information about the known malignancy. This information was qualitatively concordant with that of CE-MRI. Compared with the temporal subtraction CE-DBT technique, dual-energy CE-DBT appears less susceptible to motion artefacts.
对比增强数字乳腺断层融合摄影(CE-DBT)是一种用于成像乳腺病变形态和血管的新型方式。本研究旨在评估双能减影作为 CE-DBT 技术的可行性(先前已经描述了时间减影 CE-DBT 技术)。随着 CE-DBT 的发展,探索替代的图像采集技术将有助于其优化。在获得我们机构的机构审查委员会(IRB)批准并符合联邦健康保险流通与责任法案(HIPAA)准则的情况下,对双能 CE-DBT 进行了评估。一位 55 岁的女性患者右乳有已知的恶性肿瘤,对其进行了 MRI 和 CE-DBT 成像。CE-DBT 是在 medial lateral oblique 视图中进行的,使用 DBT 系统进行,该系统在 IRB 批准下进行了修改,允许使用 0.25mm Cu 滤波器进行高能图像采集。图像采集是通过时间和双能减影 CE-DBT 进行的。在对比前和对比后 DBT 图像组之间,单次注射碘造影剂(1.0ml/kg),随后用 60ml 生理盐水冲洗。造影剂和生理盐水以大约 2ml/s 的速度手动给药。使用滤波反投影重建图像,并将其传输到临床 PACS 工作站。双能 CE-DBT 被证明是临床可行的。在我们的病例中,双能技术能够提供关于已知恶性肿瘤的形态和动力学信息。该信息与 CE-MRI 的定性结果一致。与时间减影 CE-DBT 技术相比,双能 CE-DBT 似乎对运动伪影的敏感性较低。